학술논문
[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 26 April 2016, 7(17):23608-23632)
Subject
Language
English
ISSN
19492553